BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
World

'Every week counts' as Austria, Greece, Denmark seek quick EU OK for AstraZeneca vaccine

  • EMA, the EU drugs regulator, said last week it would review the vaccine developed by AstraZeneca and Britain's Oxford University this month under an accelerated timeline.
  • We expect that work be done day and night, that a decision be reached unbureaucratically and that Europe not fall behind.
Published Updated
By

VIENNA: Austria, Greece and Denmark will jointly pressure the European Medicines Agency to approve AstraZeneca's COVID-19 vaccine as quickly as possible, Austrian Chancellor Sebastian Kurz said on Monday, adding: "Every week counts."

Kurz was speaking before a European leaders' virtual summit on Thursday, and a day after he said Austria's lockdown was being extended until at least Feb. 7 as it tries to contain highly infectious new variants.

EMA, the EU drugs regulator, said last week it would review the vaccine developed by AstraZeneca and Britain's Oxford University this month under an accelerated timeline.

"Every week counts," Kurz told a news conference after a video call with various countries on dealing with the virus. "We expect that work be done day and night, that a decision be reached unbureaucratically and that Europe not fall behind.

"What is now needed is - based on all scientific facts, of course - an immediate and quick decision, because AstraZeneca can deliver up to two million doses in the first quarter for Austria alone, and that of course makes an enormous difference to our success in vaccinating the population."

Austria has a population of just under nine million people.

Kurz also said part of the already-approved vaccine doses being supplied by Pfizer would arrive late, after Pfizer said it was temporarily reducing deliveries to Europe.

"Yes, there will now have to be a small adjustment here or there because it currently seems as though we will receive 20% less, which will then be caught up in February at the latest," Kurz said.

Comments

Comments are closed for this article.